ADVERSE REACTIONS SECTION.
ADVERSE REACTIONS. Allergic sensitizations have been reported following oral administration of folic acid.Consult your physician immediately if adverse side effects occur.
Citing DrugCentral © 2024. License
CONTRAINDICATIONS SECTION.
CONTRAINDICATIONS. This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
Citing DrugCentral © 2024. License
DESCRIPTION SECTION.
DESCRIPTION. Dialyvite 3000 is prescription folic acid supplement with additional nutrients for kidney dialysis patients. Dialyvite 3000 is small, round, light brown, clear-coated tablet, with debossed H on one side.Each tablet contains:Folic Acid.....3 mgVitamin (d-alpha Tocopheryl Acid Succinate).....30 IU Vitamin (Ascorbic Acid).....100 mgThiamine (Thiamine Mononitrate).....1.5 mgRiboflavin.....1.7 mgNiacinamide.....20 mgVitamin B6 (Pyridoxine HCl).....25 mgVitamin B12 (Methylcobalamin).....1 mgBiotin.....300 mcgPantothenic Acid (Calcium Pantothenate).....10 mgZinc (Zinc Citrate).....15 mgSelenium (Selenium Amino Acid Chelate).....70 mcg Inactive ingredients:Microcrystalline Cellulose, Croscarmellose Sodium, Mono-and Diglycerides, Pharmaceutical Glaze, Carob (color), Starch, Calcium Stearate, Silicon Dioxide.
Citing DrugCentral © 2024. License
DOSAGE & ADMINISTRATION SECTION.
DOSAGE AND ADMINISTRATION. Take one tablet per day or use as directed by your physician, orally.
Citing DrugCentral © 2024. License
INDICATIONS & USAGE SECTION.
INDICATIONS AND USAGE. Dialyvite 3000 is prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.
Citing DrugCentral © 2024. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
PRINCIPAL DISPLAY PANEL. NDC 10542-014-09Dialyvite 3000Multivitamin Supplement for Dialysis Patients90 Tablets. Dialyvite 3000 PDP.
Citing DrugCentral © 2024. License
PRECAUTIONS SECTION.
PRECAUTIONS. Folic acid supplementation may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations progress.Keep out of reach of children.
Citing DrugCentral © 2024. License